Get startedLog in
    Picture of Quest PharmaTech logo

    QPT — Quest PharmaTech News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Oncoquest announces enrollment of first patient in phase 1/2 clinical study

    Picture of Quest PharmaTech logoQuest PharmaTech
    09/05/2017 12:00
    May 9 (Reuters) - Quest Pharmatech Inc  QPT.V :  
    * Oncoquest announces enrollment of first patient in phase 
1/2 clinical study using combination of oregovomab with 
checkpoint inhibitor nivolumab in recurrent ovarian cancer 
 
Source text for Eikon:  ID:nPn2qSB7ha  
Further company coverage:  QPT.V  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

    Recent news on Quest PharmaTech

    See all news